title: [Should high-dose buprenorphine be withdrawn from the French market?].
authors.forename: B
authors.initials: B
authors.lastname: Rolland
authors.forename: A
authors.initials: A
authors.lastname: Muyssen
authors.forename: T
authors.initials: T
authors.lastname: Danel
authors.forename: O
authors.initials: O
authors.lastname: Cottencin
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use*; D002047:Buprenorphine / Q000627:therapeutic use*; D000069479:Buprenorphine, Naloxone Drug Combination; D005602:France; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use; D058850:Opiate Substitution Treatment; D009293:Opioid-Related Disorders / Q000188:drug therapy; D063487:Prescription Drug Misuse
chemical_list: D000701:Analgesics, Opioid; D000069479:Buprenorphine, Naloxone Drug Combination; D009270:Naloxone; D002047:Buprenorphine